Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations.

Liang NC, Bello NT, Moran TH.

Int J Obes (Lond). 2013 Feb;37(2):272-8. doi: 10.1038/ijo.2012.16. Epub 2012 Feb 7.

2.

Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss.

Billes SK, Sinnayah P, Cowley MA.

Pharmacol Res. 2014 Jun;84:1-11. doi: 10.1016/j.phrs.2014.04.004. Epub 2014 Apr 19. Review.

3.

Opiate antagonists and eating behavior in humans: a review.

de Zwaan M, Mitchell JE.

J Clin Pharmacol. 1992 Dec;32(12):1060-72. Review.

PMID:
1487543

Supplemental Content

Support Center